News

December 6, 2018

New Imaging Agent Better at Detecting Signs of Prostate Cancer Recurrence, Study Reports

News

A new imaging agent for use in positron emission tomography (PET) is better than conventional imaging at detecting cancer location and spread in prostate cancer patients suspected of cancer ... Read more

December 5, 2018

ADT Increases Risk for Fractures in Older Prostate Cancer Patients, Study Shows

News

Elderly prostate cancer patients taking androgen deprivation therapy (ADT) have an increased risk for bone fractures compared to prostate cancer patients without ADT or men without prostate cancer, a ... Read more

November 29, 2018

Finasteride Use Before Prostate Cancer Diagnosis Linked to More Advanced Disease, Lower Survival, Study Finds

News

Patients who take finasteride before being diagnosed with prostate cancer tend to have more advanced and aggressive disease, as well as lower overall survival, according to a large, national study. ... Read more

November 28, 2018

European Advisory Committee Recommends Approval of Erleada for Men at Risk of Prostate Cancer Spreading

News

Janssen‘s hormone therapy Erleada (apalutamide) may soon be used in Europe for men with castration-resistant prostate cancer (CRPC) who have a high risk of their disease spreading, after the Committee for ... Read more

November 21, 2018

Radiation Treatments Delay Metastasis, Recurrence in Aggressive Prostate Cancers

News

Radiation therapy approaches — including external beam radiation therapy (EBRT) and brachytherapy — for prostate cancer patients with aggressive disease are better at extending the time to metastasis or ... Read more

November 15, 2018

Radiation and Hormone Therapy Combo May Help Prevent Cancer’s Return After Prostatectomy

News

Prostate cancer patients who show signs of disease progression after surgery to remove the prostate may benefit by combining standard therapy with short-term androgen deprivation (STAD) and pelvic lymph node ... Read more

November 14, 2018

Phase 3 Trial of Relugolix for Advanced Prostate Cancer Completes Patient Enrollment

News

A Phase 3 trial evaluating Myovant Sciences’ relugolix as a treatment for advanced prostate cancer patients who are sensitive to androgen deprivation treatments has completed patient enrollment, the company announced. The ... Read more

November 8, 2018

Phase 2 Trial of Irofulven to Treat Metastatic Castration-Resistant Prostate Cancer Opens in Denmark

News

Oncology Venture announced that patient enrollment has begun in a Phase 2 study evaluating irofulven as a possible treatment for metastatic castration-resistant prostate cancer (mCRPC). Specifically, the trial (NCT03643107) is for patients ... Read more

November 7, 2018

Prostate Cancer Foundation Grants $5.5M in Research Funding to Challenge Award Winners

News

More than $5.5 million in funding from the Prostate Cancer Foundation (PCF) will enable six teams of scientists to pursue innovative therapeutic strategies for advanced prostate cancer. Announced at the end ... Read more

November 1, 2018

Certain Prostate Cancer Patients May Benefit From Higher Radiation Doses in Fewer Sessions, Study Shows

News

Stereotactic body radiation therapy (SBRT) — a kind of radiation therapy that delivers high doses of radiation over a shorter treatment course — is as safe and effective as ... Read more